Connection
David Camidge to Sirolimus
This is a "connection" page, showing publications David Camidge has written about Sirolimus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.026 |
|
|
|
-
Besse B, Heist RS, Papadmitrakopoulou VA, Camidge DR, Beck JT, Schmid P, Mulatero C, Miller N, Dimitrijevic S, Urva S, Pylvaenaeinen I, Petrovic K, Johnson BE. A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer. Ann Oncol. 2014 Feb; 25(2):505-11.
Score: 0.026